Over the past 12 months, Compass Pathways insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Life Sciences N.V. Atai | TenPercentOwner | 0 | 6,905,774 | 6,905,774 | 34.3% | 27 Sep, 2024 |
| 2 | Ekaterina Malievskaia | Chief Innovation Officer | 3,152,848 | 3,155,122 | 6,307,970 | 31.3% | 25 Oct, 2024 |
| 3 | George Jay Goldsmith | Chief Executive Officer | 3,155,122 | 3,152,848 | 6,307,970 | 31.3% | 25 Oct, 2024 |
| 4 | Kabir Nath | Chief Executive Officer | 361,028 | 0 | 361,028 | 1.8% | 05 Aug, 2026 |
| 5 | Teri Loxam | Chief Financial Officer | 152,002 | 0 | 152,002 | 0.8% | 27 Mar, 2026 |
| 6 | Matthew A Owens | General Counsel Clo | 43,340 | 0 | 43,340 | 0.2% | 05 Feb, 2024 |
| 7 | Michael Falvey | Chief Financial Officer | 22,500 | 0 | 22,500 | 0.1% | 03 Feb, 2023 |
| 8 | David Y Norton | Director | 20,356 | 0 | 20,356 | 0.1% | 31 Mar, 2022 |
| 9 | Annalisa Jenkins | Director | 19,480 | 0 | 19,480 | 0.1% | 05 Aug, 2024 |
| 10 | Guy Goodwin | Chief Medical Officer | 8,000 | 0 | 8,000 | 0.0% | 06 Apr, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 03 Aug, 2026 | Kabir Nath | Chief Executive Officer | Disposed F | 5,962 | $11.25 | $67.07K | 361,028 | Direct |
| 27 May, 2026 | David Y Norton | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 27 May, 2026 | Daphne Karydas | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 27 May, 2026 | Justin D. Gover | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 27 May, 2026 | Wayne Joseph Riley | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 27 May, 2026 | Kathleen Tregoning | Director | Acquired A | 41,119 | $0.00 | $0 | 41,119 | Direct |
| 27 May, 2026 | Gino Santini | Director | Acquired A | 30,158 | $0.00 | $0 | 30,158 | Direct |
| 27 May, 2026 | Robert Mcquade | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 27 May, 2026 | Jeffrey M Jonas | Director | Acquired A | 21,110 | $0.00 | $0 | 21,110 | Direct |
| 26 Mar, 2026 | Teri Loxam | Chief Financial Officer | Acquired A | 75,000 | $0.00 | $0 | 152,002 | Direct |
| 26 Mar, 2026 | Kabir Nath | Chief Executive Officer | Acquired A | 175,000 | $0.00 | $0 | 366,990 | Direct |
| 26 Mar, 2026 | Guy Goodwin | Chief Medical Officer | Acquired A | 55,000 | $0.00 | $0 | 55,000 | Direct |
| 26 Mar, 2026 | Guy Goodwin | Chief Medical Officer | Acquired A | 115,600 | $0.00 | $0 | 115,600 | Direct |
| 26 Mar, 2026 | Teri Loxam | Chief Financial Officer | Acquired A | 157,635 | $0.00 | $0 | 157,635 | Direct |
| 26 Mar, 2026 | Kabir Nath | Chief Executive Officer | Acquired A | 367,815 | $0.00 | $0 | 367,815 | Direct |
| 11 Mar, 2026 | Kabir Nath | Chief Executive Officer | Disposed F | 13,131 | $6.89 | $90.47K | 191,990 | Direct |
| 11 Mar, 2026 | Teri Loxam | Chief Financial Officer | Disposed F | 1,781 | $6.89 | $12.27K | 77,002 | Direct |
| 02 Mar, 2026 | Teri Loxam | Chief Financial Officer | Disposed F | 4,467 | $7.02 | $31.36K | 78,783 | Direct |
| 02 Feb, 2026 | Kabir Nath | Chief Executive Officer | Disposed F | 16,181 | $6.61 | $106.96K | 205,121 | Direct |
| 29 Oct, 2025 | Jeffrey M Jonas | Director | Acquired A | 52,000 | $0.00 | $0 | 52,000 | Direct |